NCT01356511
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +15 more
- Locations
-
- Qilu Hospital, Shandong University Jinan, Shandong, China
Clinical trial condition
Thrombotic Microangiopathies
Explore clinical trials studying Thrombotic Microangiopathies. Study availability and eligibility vary by location and protocol.
404 public trials
103 recruiting studies
Thrombotic Microangiopathies trial results
NCT02351622
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Shandong University Qilu hospital Jinan, Shandong, China
NCT01390649
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- UMHAT "Dr. Georgi Stranski" Clinic of Haematology Pleven, Bulgaria
- UMHAT "Sv. Georgi" Clinic of Haematology Plovdiv, Bulgaria
- Tokuda Hospital Sofia, Bulgaria
- Emergency Clinical County Hospital Baia Mare Baia Mare, Romania
NCT00699140
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +13 more
- Locations
-
- Federal Research Clinical Centre of Pediatric Hematology, Oncology and Immunology Roszdrava Moscow, Russia
- Haematology Research Centre of Russian Academy of Medical Science Moscow, Russia
- Hospital General Vall d´Hebron Barcelona, Spain
- . Hospital de León León, Spain
NCT02085993
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Research Site Innsbruck, Austria
- Research Site Leoben, Austria
- Research Site Bruges, Belgium
- Research Site Ghent, Belgium
Completed
Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS
NCT00844545
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Atlanta, Georgia, United States
- Fort Wayne, Indiana, United States
- New York, United States
- New York, United States
Completed
Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS
NCT00844428
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Toronto, Canada
- Bois-Guillaume, France
- Bordeaux, France
- Lyon, France
NCT00838513
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Toronto, Canada
- Bois-Guillaume, France
- Bordeaux, France
- Lyon, France
Completed
Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS
NCT00844844
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Atlanta, Georgia, United States
- Fort Wayne, Indiana, United States
- New York, United States
- New York, United States
NCT01193348
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +15 more
- Locations
-
- Atlanta, Georgia, United States
- Hackensack, New Jersey, United States
- Corpus Christi, Texas, United States
- Spokane, Washington, United States